DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aldactone (Spironolactone) - Adverse Event Reports - All Cases - Drug Interaction

 



Index of reports > All cases (253) > Cases with Drug Interaction (30)

Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes all cases where reactions include drug interaction.

 Reports 1 - 25 of 30   Next >>

Adverse event in receiving Aldactone (Spironolactone)

Reported by a consumer/non-health professional from France on 2007-10-29

Patient:

Adverse reactions / side effects: Blood Urea Increased, Overdose, Drug Interaction, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Dosage: 250 mg, qd
    Administration route: Oral
    End date: 2007-09-08

Lasix
    Dosage: 40 mg, bid
    Administration route: Oral
    End date: 2007-09-08

Ramipril
    Dosage: 2.5 mg, bid
    Administration route: Oral
    End date: 2007-09-08

Other drugs received by patient: Ditropan / 00538901 /; Escitalopram; Ogast; Previscan / 00789001 /; Lyrica; Havlane; Novomix / 01475801 /



Adverse event in 71 year old male receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification on 2007-10-17

Patient: 71 year old male

Adverse reactions / side effects: Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Administration route: Oral
    End date: 2007-09-08

Lasix
    Administration route: Oral
    End date: 2007-09-08

Ramipril
    Administration route: Oral
    End date: 2007-09-08

Other drugs received by patient: Ditropan; Escitalopram; Ogast; Previscan / 00789001 /; Lyrica; Havlane; Novomix / 01475801 /



Adverse event in receiving Aldactone (Spironolactone)

Reported by a consumer/non-health professional from France on 2007-07-26

Patient:

Adverse reactions / side effects: LOW Cardiac Output Syndrome, Vomiting, Dyspnoea, Hyperkalaemia, Drug Interaction, Haemodialysis, Cardiac Failure, Renal Tubular Necrosis, Hypoperfusion, Blood Creatinine Increased, Renal Failure Acute, Anuria

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Administration route: Oral
    End date: 2007-05-08

Altace
    Administration route: Oral
    End date: 2007-05-08

Celebrex
    Administration route: Oral
    Indication: Pain in Extremity

Cordarone / 00133102 /
    Dosage: 200 mg, unk
    Administration route: Oral

Lasilix / 00032601 /
    Administration route: Oral
    End date: 2007-05-08

Other drugs received by patient: Previscan / 00789001 /



Adverse event in 80 year old male receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification from Spain on 2007-07-13

Patient: 80 year old male

Adverse reactions / side effects: Localised Infection, Diarrhoea, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Dosage: (25 mg qd oral)
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    End date: 2007-02-15

Augmentin '250'
    Indication: Infection

Enalapril Maleate
    Dosage: 5 mg qd oral
    Administration route: Oral
    Indication: Cardiac Failure Congestive

Seguril (Seguril) 40 MG
    Dosage: (40 mg qd oral)
    Administration route: Oral
    Indication: Cardiac Failure Congestive

Other drugs received by patient: Tardyferon / 00023503 /; Fraxiparina; Nimustine



Adverse event in 85 year old female receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-07-06

Patient: 85 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Syncope, Hyperkalaemia, Dizziness, Drug Interaction, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Olmesartan Medoxomil
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-02-07
    End date: 2007-05-15

Other drugs received by patient: Amitriptyline HCL; Omeprazole; Ferrous Sulfate; Folic Acid; Diltiazem



Adverse event in 71 year old male receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-07-06

Patient: 71 year old male

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Acovil
    Administration route: Oral
    Indication: Hypertensive Heart Disease

Antiinflammatory / Antirheumatic NON-Steroids
    Administration route: Oral
    Indication: Arthralgia

Other drugs received by patient: Amoxicillin + Clavulanate Potassium; Dianben; Atacand; Coropres; Digoxin; Sintrom; Lipemol; Spiriva



Adverse event in 80 year old male receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification on 2007-07-05

Patient: 80 year old male

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Administration route: Oral
    End date: 2007-02-15

Renitec / 00574901 /
    Administration route: Oral

Seguril / 00032601 /
    Administration route: Oral

Other drugs received by patient: Tardyferon / 00023503 /; Fraxiparina; Nimustina



Adverse event in 85 year old female receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-07-05

Patient: 85 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Syncope, Drug Interaction, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aldactone
    Dosage: 100 mg (100 mg, 1 tab daily), per oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-02-07
    End date: 2007-05-15

Ixia (Olmesartan Medoxomil) (20 Milligram, Tablet) (Olmesartan Medoxom
    Dosage: 20 mg (20 mg, 1 tab daily) per oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-02-07
    End date: 2007-05-15

Other drugs received by patient: Tryptizol (Amitriptyline Hydrochloride) (Amitriptyline Hydrochloride); Omeprazol (Omeprazole) (Omeprazole); Fero-Gradumet (Ferrous Sulfate) (Ferrous Sulfate); Acfol (Folic Acid) (Folic Acid); Carreldon Retard (Diltiazem) (Diltiazem)



Adverse event in 80 year old male receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-07-05

Patient: 80 year old male

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Renitec
    Administration route: Oral
    Indication: Cardiac Failure Congestive

Seguril
    Administration route: Oral
    Indication: Cardiac Failure Congestive

Other drugs received by patient: Tardyferon; Fraxiparina; Nimustine



Adverse event in 87 year old female receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-06-22

Patient: 87 year old female

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Enalapril
    Dosage: daily dose:20mg
    Administration route: Oral
    Indication: Hypertension

Seguril
    Administration route: Oral
    Indication: Hypertension

Other drugs received by patient: Coropres; Oxis; Spiriva



Adverse event in 71 year old male receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-06-22

Patient: 71 year old male

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Acovil
    Administration route: Oral
    Indication: Hypertensive Heart Disease

Other drugs received by patient: Antiinflammatory / Antirheumatic NON-Steroids; Amoxicillin + Clavulanate Potassium; Dianben; Atacand; Coropres; Digoxin; Sintrom; Lipemol; Spiriva



Adverse event in 87 year old female receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification on 2007-06-12

Patient: 87 year old female

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Administration route: Oral
    End date: 2005-05-23

Enalapril Maleate
    Administration route: Oral
    End date: 2005-05-23

Seguril / 00032601 /
    Administration route: Oral
    End date: 2005-05-01

Other drugs received by patient: Coropres; Oxis Turbuhaler; Spiriva



Adverse event in 59 year old male receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-05-03

Patient: 59 year old male

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Antiinflammatory / Antirheumatic NON-Steroids
    Dosage: freq:prn
    Administration route: Oral
    Indication: Arthropathy
    Start date: 2007-03-11
    End date: 2007-01-01

Seguril
    Administration route: Oral
    Start date: 2007-03-15
    End date: 2007-03-22

Other drugs received by patient: Enalapril; Sustiva; Kaletra; Septra; Coropres; Uniket; Adiro; Omeprazole; Ziagen



Adverse event in 72 year old male receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-05-03

Patient: 72 year old male

Adverse reactions / side effects: Hyperkalaemia, Atrioventricular Block Complete, Drug Interaction, Renal Failure Acute, Haemodialysis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Furosemide
    Dosage: daily dose:40mg-text:40 mg once daily
    Administration route: Oral
    Indication: Essential Hypertension

Manidon
    Dosage: daily dose:240mg-text:240 mg daily
    Administration route: Oral
    Indication: Cardiac Disorder

Renitec
    Dosage: daily dose:80mg-text:40 mg twice daily
    Administration route: Oral
    Indication: Essential Hypertension

Other drugs received by patient: Allopurinol; Atorvastatin Calcium



Adverse event in 74 year old male receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26

Patient: 74 year old male

Adverse reactions / side effects: Renal Failure, Hyperkalaemia, Drug Interaction

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Cardensiel
    Dosage: daily dose:5mg-freq:daily
    Administration route: Oral
    Indication: Cardiomyopathy

Kenzen
    Dosage: daily dose:24mg-freq:daily
    Administration route: Oral
    Indication: Cardiomyopathy

Piroxicam
    Dosage: text:1 dose form-freq:daily
    Administration route: Oral

Other drugs received by patient: Lantus; Lasix; Lipur; Metformin HCL; Previscan; Amiodarone HCL; Paracetamol; Ditropan; Novorapid



Adverse event in 74 year old male receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification from France on 2007-04-20

Patient: 74 year old male

Adverse reactions / side effects: Heart Rate Decreased, Overdose, Renal Failure, Hyperkalaemia, Bundle Branch Block Left, Drug Interaction, Atrioventricular Block First Degree

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Dosage: 1 dosage forms (1 dosage forms, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy
    End date: 2007-03-03

Cardensiel 5 Mg(bisoprolol Fumarate)
    Dosage: 5 mg (5 mg, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy

Kenzen (Candesartan Cilexetil)
    Dosage: 24 mg (24 mg, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy
    End date: 2007-03-03

Lantus
    Dosage: 1 dosage forms (1 dosage forms, 1 d) subcutaneous
    Indication: Diabetes Mellitus

Lasix
    Dosage: 40 mg (40 mg, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy

Proxalyoc (Piroxicam)
    Dosage: 1 dosage forms (1 dosage forms, 1 d) oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    End date: 2007-03-02

Other drugs received by patient: Gemfibrozil; Metformin HCL; Previscan (Fluindione); Amiodarone HCL; Acetaminophen; Ditropan; Novorapid (Insulin Aspart)



Adverse event in 74 year old male receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification from France on 2007-04-17

Patient: 74 year old male

Adverse reactions / side effects: Heart Rate Decreased, Renal Failure, Hyperkalaemia, Wrong Drug Administered, Drug Interaction, Bundle Branch Block Left, Blood Pressure Abnormal, Atrioventricular Block First Degree

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Dosage: 1 dosage forms (1 dosage forms, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy
    End date: 2007-03-03

Bisoprolol Fumarate
    Dosage: 5 mg (5 mg, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy

Kenzen (Candesartan Cilexetil)
    Dosage: 25 mg (25 mg, 1 d) oral
    Administration route: Oral
    Indication: Cardiomyopathy
    End date: 2007-03-03

Other drugs received by patient: Lantus; Proxalyoc (Piroxicam); Lasix; Gemfibrozil; Metformin HCL; Previscan (Fluindione); Amiodarone HCL; Acetaminophen; Ditropan; Novorapid (Insulin Aspart)



Adverse event in 80 year old male receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-13

Patient: 80 year old male, weighing 73.0 kg (160.6 pounds)

Adverse reactions / side effects: Vomiting, Hypotension, Hyponatraemia, Drug Interaction, Loss of Consciousness, Haemoglobin Decreased, Syncope, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Furosemide
    Administration route: Oral

Nifedipine
    Administration route: Oral

Rilmenidine
    Administration route: Oral

Other drugs received by patient: Losartan Postassium; Omix; Carbimazole; Aranesp; Gliclazide



Adverse event in 80 year old male receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-09

Patient: 80 year old male, weighing 73.0 kg (160.6 pounds)

Adverse reactions / side effects: Syncope, Hypotension, Hyponatraemia, Drug Interaction, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Furosemide
    Administration route: Oral

Nifedipine
    Administration route: Oral

Rilmenidine
    Administration route: Oral

Other drugs received by patient: Losartan Postassium; Omix; Carbimazole; Aranesp; Gliclazide



Adverse event in 88 year old female receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-05

Patient: 88 year old female

Adverse reactions / side effects: Hyponatraemia, Drug Interaction, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Lasix
    Administration route: Oral
    Indication: Hypertensive Cardiomyopathy

Other drugs received by patient: Stagid; Amlor; Fozitec; Insulatard; Pariet 10; Previscan; Stilnox; Digoxin; Diamicron



Adverse event in 80 year old male receiving Aldactone (Spironolactone)

Reported by a individual with unspecified qualification on 2007-04-04

Patient: 80 year old male, weighing 73.0 kg (160.6 pounds)

Adverse reactions / side effects: Vomiting, Hypotension, Drug Interaction, Hyponatraemia, Blood Creatinine Increased, Loss of Consciousness

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Administration route: Oral
    Start date: 2006-11-15

Chronadalate
    Administration route: Oral

Cozaar
    Administration route: Oral

Hyperium / 00939801 /
    Administration route: Oral

Lasilix / 00032601 /
    Administration route: Oral

Other drugs received by patient: Omix; NEO-Mercazole TAB; Aranesp; Diamicron



Adverse event in 88 year old female receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-03-23

Patient: 88 year old female

Adverse reactions / side effects: Hepatojugular Reflux, Hyponatraemia, Drug Interaction, Bundle Branch Block Left, Status Epilepticus, Arrhythmia, Oedema Peripheral, Protein Total Increased, Metabolic Disorder, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Lasix
    Administration route: Oral
    Indication: Hypertensive Cardiomyopathy

Other drugs received by patient: Stagid; Amlodipine; Fozitec; Insulatard



Adverse event in 83 year old female receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-03-19

Patient: 83 year old female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Hyperkalaemia, Folate Deficiency, Iron Deficiency, Atrial Fibrillation, Drug Interaction, Fall, Myalgia, Gastroenteritis, Asthenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Enalapril Maleate
    Administration route: Oral

Lasix
    Administration route: Oral

Potassium Chloride
    Dosage: text:2 dose form-freq:daily
    Administration route: Oral

Other drugs received by patient: Levothyroxine Sodium



Adverse event in 76 year old male receiving Aldactone (Spironolactone)

Reported by a health professional (non-physician/pharmacist) from France on 2007-03-05

Patient: 76 year old male

Adverse reactions / side effects: Hyperkalaemia, Drug Interaction

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Aldactone
    Indication: Hypertension

Diffu K
    Dosage: text:1 df-freq:daily
    Administration route: Oral
    Indication: Hypokalaemia

Kenzen
    Dosage: text:1 df-freq:daily
    Administration route: Oral
    Indication: Cardiomyopathy
    End date: 2006-08-02

Kenzen
    Indication: Hypertension

Lasix
    Administration route: Oral
    Indication: Cardiomyopathy

Lasix
    Indication: Hypertension

Other drugs received by patient: Hyperium; Hyperium; Allopurinol; Kardegic; Stablon; Zoxan LP; Mopral; Rilmenidine Dihydrogen Phosphate



Adverse event in 82 year old female receiving Aldactone (Spironolactone)

Reported by a pharmacist from Spain on 2007-02-08

Patient: 82 year old female

Adverse reactions / side effects: Confusional State, Hyponatraemia, Drug Interaction

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone (Spironolactone)

Other drugs received by patient possibly interacting with the suspect drug:
Furosemide
    Administration route: Oral
    Indication: Cardiac Failure

Mirtazapine
    Administration route: Oral
    Indication: Depression
    Start date: 2006-01-17
    End date: 2006-11-22

Other drugs received by patient: Rivotril; Digoxin; Omeprazole



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009